GlassScriptPhysician profile
Daniel M Kawash
NPI 1043304686
$1,275.11
in general payments reported to CMS, 2019-2025
13 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.60 · 2022: $274 · 2023: $236 · 2024: $288 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $956.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $544.97 | 2022-2025 | Va-Lcp, Motoband, Na |
| Stryker Corporation | $260.99 | 2022-2024 | Gamma |
| Pacira Pharmaceuticals Incorporated | $125.13 | 2024 | Iovera |
| Davol INC. | $73.14 | 2023-2024 | Arista Ah Flexitip |
| Ferring Pharmaceuticals INC. | $71.39 | 2022-2023 | Euflexxa |
| Avanos Medical | $43.94 | 2022 | |
| Foundation Fusion Solutions, LLC | $36.61 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $30.00 | 2021 | |
| Boston Scientific Corporation | $24.49 | 2023 | |
| Bioventus LLC | $21.62 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.81 | 2023 | Seglentis |
| Pacira Therapeutics, INC. | $14.60 | 2021 | |
| Ethicon US, LLC | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kawash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.